Company Filing History:
1 out of 101 
1 out of 206 Years Active: 2010
Title: Morag Ann MacCall Easson: A Pioneer in Pharmaceutical Innovations
Introduction
Morag Ann MacCall Easson, based in Edinburgh, UK, is a notable inventor known for her significant contribution to the pharmaceutical industry. With a focus on developing novel compounds, she has made strides in the field of pharmaceuticals, particularly in the treatment of central nervous system diseases.
Latest Patents
Morag holds a patent for her invention related to novel 1,5,7-trisubstituted benzimidazole derivatives. This patent includes pharmaceutical compositions containing these compounds and methods of treatment therewith. The compounds she developed are particularly useful in treating conditions that require modulation of the GABA receptor complex, showcasing her innovation in addressing complex neurological disorders.
Career Highlights
Throughout her career, Morag has been associated with prestigious companies such as N.V. Organon and Neurosearch A/S. Her work in these organizations has not only provided her with valuable experience but has also helped advance research and development in the pharmaceutical field.
Collaborations
Collaboration has been a vital part of Morag's success. She has worked alongside talented professionals like Niall Morton Hamilton and Susan Elizabeth Napier. These partnerships have contributed to her understanding and implementation of cutting-edge research in her field.
Conclusion
In summary, Morag Ann MacCall Easson is an accomplished inventor whose innovative work in pharmaceutical compositions has the potential to make a significant impact on the treatment of central nervous system disorders. Her contributions reflect the importance of creativity and collaboration in advancing medical research, pointing to a promising future in the realm of pharmaceutical innovations.